MURUGAPPAN M; BABU B; SHANKAR V; YUSUF M; JAWAHAR N. ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT. Asian Journal of Pharmaceutical and Clinical Research, [S. l.], v. 18, n. 4, p. 44–51, 2025. DOI: 10.22159/ajpcr.2025v18i4.54004. Disponível em: https://www.journals.innovareacademics.in/index.php/ajpcr/article/view/54004. Acesso em: 6 dec. 2025.